- Home
- Aesthetic gynaecology
- Vaginal atrophy
- Vaginal atrophy
Vaginal atrophy: symptoms, causes and why it does not improve on its own
Unlike hot flushes, vaginal atrophy is chronic and does not go away on its own, but it can be treated. See the symptoms, the causes and what the evidence says about each option.
Quando existir, entra aqui e também no cartão da página do blog.
In this article
Many women expect menopausal symptoms to pass with time. With hot flushes, that usually happens. With vaginal atrophy, it does not: the dryness, burning and pain during sex tend to persist or worsen over the years (Portman and Gass, 2014, NAMS, 2020).
The good news is that vaginal atrophy has treatments backed by good scientific evidence. The problem is that many women never discuss it with their doctor, out of embarrassment or because they think it is ‘normal for their age’ (Nappi and Kokot-Kierepa, 2012).
Three ideas to remember.
Fica por baixo do resumo, se existir uma segunda foto.
What vaginal atrophy is
The tissues of the vulva, vagina, urethra and bladder have oestrogen receptors. When oestrogen falls, these tissues change (Portman and Gass, 2014, NAMS, 2020):
- the vaginal mucosa becomes thinner, paler and less elastic;
- it loses its natural folds and bleeds more easily;
- it produces fewer secretions;
- the vaginal pH rises, lactobacilli decrease and the protective flora weakens;
- the vagina can become shorter and narrower, and the entrance more sensitive.
Since 2014, scientific societies have preferred the term genitourinary syndrome of menopause, because the changes are not limited to the vagina: they also include the vulva and the urinary tract (Portman and Gass, 2014).
Symptoms
| Area | Most common symptoms |
|---|---|
| Vagina and vulva | dryness, burning, itching, irritation, a feeling of tightness, discharge different from usual |
| Sex | pain on penetration, less lubrication, small bleeds after sex, less desire in anticipation of pain |
| Urinary tract | urgency, frequent trips to the toilet, burning when passing urine, recurrent urinary infections |
Not all women have all the symptoms. Some only notice discomfort during sex; others feel it day to day, when walking, sitting or wearing tight clothing.
Causes
The cause is always lack of oestrogen. The most common situations are:
- natural menopause, the most frequent cause;
- surgical removal of the ovaries, which causes an immediate menopause;
- breast cancer treatments, such as aromatase inhibitors and tamoxifen (Faubion et al., 2018);
- chemotherapy and pelvic radiotherapy;
- medicines that suppress the ovaries, used in endometriosis, fibroids or assisted reproduction;
- breastfeeding and the postpartum period, temporarily;
- premature ovarian insufficiency, before the age of 40.
Smoking, lack of sexual activity and no vaginal births have been associated with more marked symptoms, but they are not causes in themselves.
Why it does not improve on its own
Hot flushes result from the brain adapting to the new hormonal reality, which is why they tend to diminish over the years. Vaginal atrophy is different: it results from the continued lack of oestrogen in the tissues themselves. As long as that lack persists, the tissues keep losing thickness and elasticity (NAMS, 2020).
In practice, this means that:
- without treatment, symptoms usually persist or worsen;
- when treatment is stopped, symptoms tend to return;
- the more time passes, the harder it may be to recover elasticity and comfort.
For this reason, vaginal atrophy should be seen as a chronic condition that needs a long-term plan, not a passing nuisance.
How the diagnosis is made
Diagnosis is clinical. The doctor talks about the symptoms and examines the vulva and vagina, looking for thin, pale mucosa, loss of folds, small points of bleeding or narrowing (NAMS, 2020). They may measure the vaginal pH, which is usually above 5.
The appointment also serves to rule out other causes with similar symptoms, such as infections, skin conditions of the vulva (for example lichen sclerosus) or contact allergies. That is why it is not a good idea to assume it is atrophy without being examined.
Treatments
Treatment depends on the severity of symptoms, health history and each woman's preferences (NAMS, 2020).
| Option | For whom | What the evidence says |
|---|---|---|
| Vaginal lubricants and moisturisers | first line for mild symptoms | relieve dryness and pain during sex, but do not reverse the changes in the tissues |
| Low-dose vaginal oestrogen (cream, pessary, vaginal tablet or ring) | moderate to severe symptoms, or those that do not improve with moisturisers | the treatment with the most evidence; improves symptoms and tissues, with minimal absorption into the blood (Lethaby et al., 2016) |
| Vaginal prasterone (DHEA) | alternative to vaginal oestrogen | improves symptoms and pain during sex in controlled trials (NAMS, 2020) |
| Ospemifene (oral tablet) | pain during sex when vaginal treatment is not wanted | effective in controlled trials, with contraindications to be assessed (NAMS, 2020) |
| Pelvic floor physiotherapy | pain during sex, associated muscle tension | a useful complement to other treatments |
| Vaginal laser and radiofrequency | still under study | conflicting results; a rigorous trial of CO2 laser showed no difference compared with sham treatment (Li et al., 2021) |
Vaginal oestrogen also reduces recurrent urinary infections in postmenopausal women (Perrotta et al., 2008).
History of breast cancer: treatment should be decided with the oncology team. Moisturisers are the first option, and vaginal oestrogen may be considered in some cases, after discussion case by case (Faubion et al., 2018).
Laser and radiofrequency: the evidence does not yet allow them to be recommended as a first-line treatment (NAMS, 2020, Li et al., 2021), and the US FDA warned in 2018 that these devices are not approved to treat menopausal symptoms and may cause burns, scarring and pain (Medsafe, 2018).
When to see a doctor
Any vaginal bleeding after the menopause should be assessed by a doctor, even if it is slight.
If you have doubts about your symptoms, call SNS 24 (808 24 24 24). If you have heavy bleeding, severe pain or a high fever, call 112.
At Luxmed Clinic
At the gynaecological aesthetics consultation, we assess the symptoms, medical history and medication, and examine the vulva and vagina to confirm the diagnosis and rule out other causes.
Based on that assessment, we propose a plan tailored to you, which may include everyday measures, local treatment or other options, explaining what the scientific evidence supports in each case. When necessary, we work together with your doctor or oncologist.
Talk to us
The assessment is a conversation, with no obligation. Tell us what concerns you and our team will reply.
This article is for information only and does not replace a medical assessment. Results vary from person to person.
Frequently asked questions
Can vaginal atrophy be cured?
It is not cured in the sense of disappearing for ever, because the lack of oestrogen persists. But symptoms can be well controlled with continued treatment.
Does vaginal atrophy go away on its own?
No. Unlike hot flushes, it tends to persist or worsen over the years if left untreated.
What is the difference between vaginal atrophy and vaginal dryness?
Dryness is a symptom, which can have several causes. Atrophy is a change in the tissues caused by lack of oestrogen, and dryness is one of its symptoms.
Is vaginal oestrogen safe?
At a low dose, absorption into the blood is minimal and the available studies show a good safety profile. In women with a history of breast cancer, the decision should be made with the oncologist.
How long does treatment take to work?
With vaginal oestrogen, many women notice improvement in the first few weeks, but the full effect can take 2 to 3 months.
Can vaginal atrophy cause urinary infections?
It can make them more likely, because the protective vaginal flora decreases. Vaginal oestrogen reduces the risk of recurrent urinary infections after the menopause.
Does laser solve vaginal atrophy?
The evidence is still insufficient. Some studies show improvement, but a rigorous trial with sham treatment found no differences. It should not replace the treatments with more evidence.
Scientific references 8
- Portman DJ, Gass ML; Vulvovaginal Atrophy Terminology Consensus Conference Panel. Genitourinary syndrome of menopause: new terminology for vulvovaginal atrophy from the International Society for the Study of Women's Sexual Health and The North American Menopause Society. Menopause. 2014;21(10):1063-8. Artigo
- The North American Menopause Society. The 2020 genitourinary syndrome of menopause position statement of The North American Menopause Society. Menopause. 2020;27(9):976-92. Guideline
- Nappi RE, Kokot-Kierepa M. Vaginal Health: Insights, Views & Attitudes (VIVA): results from an international survey. Climacteric. 2012;15(1):36-44. Artigo
- Lethaby A, Ayeleke RO, Roberts H. Local oestrogen for vaginal atrophy in postmenopausal women. Cochrane Database Syst Rev. 2016;(8):CD001500. Revisão Cochrane
- Li FG, Maheux-Lacroix S, Deans R, et al. Effect of fractional carbon dioxide laser vs sham treatment on symptom severity in women with postmenopausal vaginal symptoms: a randomized clinical trial. JAMA. 2021;326(14):1381-9. Artigo
- Perrotta C, Aznar M, Mejia R, Albert A, Ng CW. Oestrogens for preventing recurrent urinary tract infection in postmenopausal women. Cochrane Database Syst Rev. 2008;(2):CD005131. Revisão Cochrane
- Faubion SS, Larkin LC, Stuenkel CA, et al. Management of genitourinary syndrome of menopause in women with or at high risk for breast cancer: consensus recommendations from The North American Menopause Society and The International Society for the Study of Women's Sexual Health. Menopause. 2018;25(6):596-608. Guideline
- Medsafe (Nova Zelândia). Safety Information: energy-based devices used for vaginal «rejuvenation» or vaginal cosmetic procedures (relays the USFDA safety communication of July 2018). Wellington: Medsafe; 2018. Site
Keep exploring


